Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2002
10/24/2002US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002EP1212298A4 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine
10/24/2002DE10119204A1 Production of new or known 5-aryl-1,3,3-trimethyl-2-methylene-indoline derivatives useful in compositions for dyeing keratin and other fibers, especially human hair
10/24/2002CA2443906A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/24/2002CA2443577A1 Nicotinic acetylcholine receptor ligands
10/23/2002EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002EP1250333A1 Dendrimer precursor dyes for imaging
10/23/2002EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002EP1250314A2 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
10/23/2002EP1250094A1 Tunable indocyanine dyes for biomedical applications
10/23/2002EP1250093A1 Novel indocyanine dyes
10/23/2002EP1250092A1 Novel dyes
10/23/2002EP1032631B1 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
10/23/2002EP1000063B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
10/23/2002EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002CN1375490A Novel indeno indolone compound, its preparation method and drug composition comprising the same
10/23/2002CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/23/2002CN1092958C Melatonic derivatives for use in treating sleep disorders
10/22/2002US6469224 Reacting a phosphazenium compound with a halogenated aromatic compounds, especially chlorinated aromatic compounds
10/22/2002US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002US6469193 Efficient synthesis of alkyl carbonates
10/22/2002US6469181 Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
10/22/2002US6469046 Fabh inhibitors which are useful as antibiotics for the treatment of gram positive and gram negative bacterial infections
10/22/2002US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002US6469043 Antiangiogenic agent with antitumor, antimetastatic properties which shows high safety
10/22/2002US6469042 Analgesics for migraines
10/22/2002US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002US6469027 N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
10/22/2002US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002US6469006 Particularly for treating hiv infections
10/22/2002US6468996 Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
10/22/2002US6468990 Method of inhibiting binding of nerve growth factor to p75 NTR receptor
10/22/2002CA2253914C Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
10/17/2002WO2002082185A1 Perfluoroalkylsulfonic acid compounds for photoresists
10/17/2002WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002WO2002081447A1 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
10/17/2002WO2002081446A1 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
10/17/2002WO2002081445A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
10/17/2002WO2002081444A1 1-indolyl derivatives, use thereof for production of medicaments, a method for production of said 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
10/17/2002WO2002081443A1 Novel guanidino compounds
10/17/2002WO2002080957A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/17/2002WO2002068414A3 Analogs of thalidomide as potential angiogenesis inhibitors
10/17/2002WO2002067053A3 High speed photothermographic materials containing tellurium compounds and methods of using same
10/17/2002WO2002050081A3 Antimicrobial agents
10/17/2002WO2002042292A3 Indol derivative and their use as inhibitors of p38 kinase
10/17/2002WO2002032860A3 Dynamic organ function monitoring agents
10/17/2002US20020151750 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide
10/17/2002US20020151718 Synthesis of pyrrole amides
10/17/2002US20020151546 HIV protease inhibitors based on amino acid derivatives
10/17/2002DE10118551A1 New 2-aza-bicyclo (2.2.1) heptane derivatives, are nicotinic acetyl choline receptor ligands useful for e.g. treating schizophrenia, depression or neurodegenerative diseases
10/17/2002CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002CA2442695A1 Indolinones substituted in the 6-position, the preparation thereof and their use as medicaments
10/17/2002CA2440196A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002EP1248769A2 Carbazole derivatives as inhibitors of spla2
10/16/2002EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002EP0944596B1 1-acryloylindoline derivatives and their use as prodrugs of anticancer agents
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0930292B1 Process for preparing beta-amino-alpha-hydroxy acid derivatives
10/16/2002EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002EP0741567B1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
10/16/2002CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/16/2002CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002CN1092639C Benzene-fused heterocyclic derivative and use thereof
10/15/2002US6465693 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
10/15/2002US6465661 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10/15/2002US6465503 Selective urokinase inhibitors
10/15/2002US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002US6465494 Methods for treatment of cystic fibrosis
10/15/2002US6465482 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002US6465445 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002CA2112690C Amino acid derivative
10/15/2002CA2056411C Peroxyacid manufacture
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079153A1 Method for producing tryptamine derivatives
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078692A1 Method of treatment
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
10/10/2002WO2002043667A3 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
10/10/2002WO2001078780A1 Preventives/remedies for alzheimer's disease
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002WO2001049678A9 Substituted phenyl-piperazine derivatives, their preparation and use
10/10/2002US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
10/10/2002US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002US20020147209 Cycloalkano-indole and -azaindole derivatives
10/10/2002DE10117441A1 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate 1-indolyl derivatives, to their use for the preparation of medicaments, a process for preparing the 1-indolyl and 1-indolyl derivatives containing preparations pharmzeutische
10/10/2002DE10117204A1 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinones, their preparation and their use as medicaments
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 458